Pharmaceutical Microbiology Conference 2017

The bacterial culture media segment accounted for the largest share of the global microbiology culture market in 2014. This segment is likely to continue its increased share until 2023 due to an expected rise in application in food microbiology, pharmaceutical microbiology, and disease research. The comprehensive agenda will include presentations from both regulatory and industry experts sharing recent case studies and developing trends in the field of pharmaceutical microbiology. KEY SESSIONS: Microbial contamination in aseptic manufacturing environments Risk assessments in fungal spore and bacterial spore excursions: Case studies Optimising rapid microbial-detection methods Tackling the current challenge of biofilms Flow cytometry technology and its applications CHAIRMAN: Oliver Chancel, Sterility and Aseptic Process Assurance Expert, Merial SAS 2 EU REGULATORY AUTHORITY SPEAKERS: Michael Whaley, Senior Pharmacopoeial Scientist, MHRA Ingo Spreitzer, Deputy Head Section Microbial Safety, Paul Ehrlich Institute